Liberty Mutual Group Asset Management Inc. decreased its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 25.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,897 shares of the medical instruments supplier’s stock after selling 4,071 shares during the period. Liberty Mutual Group Asset Management Inc.’s holdings in DENTSPLY SIRONA were worth $742,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Howard Hughes Medical Institute increased its position in DENTSPLY SIRONA by 134.9% in the first quarter. Howard Hughes Medical Institute now owns 2,751 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 1,580 shares during the last quarter. Penserra Capital Management LLC increased its position in DENTSPLY SIRONA by 9.5% in the first quarter. Penserra Capital Management LLC now owns 2,760 shares of the medical instruments supplier’s stock valued at $172,000 after buying an additional 240 shares during the last quarter. Howland Capital Management LLC purchased a new position in DENTSPLY SIRONA during the first quarter valued at $203,000. TNB Financial purchased a new position in DENTSPLY SIRONA during the first quarter valued at $259,000. Finally, Atria Investments LLC boosted its stake in shares of DENTSPLY SIRONA by 6.3% in the first quarter. Atria Investments LLC now owns 4,473 shares of the medical instruments supplier’s stock worth $279,000 after buying an additional 265 shares during the period. 94.92% of the stock is owned by institutional investors and hedge funds.
Shares of DENTSPLY SIRONA Inc. (NASDAQ XRAY) traded up 0.19% on Wednesday, reaching $63.17. The company had a trading volume of 997,346 shares. DENTSPLY SIRONA Inc. has a 52-week low of $55.00 and a 52-week high of $65.68. The company has a 50 day moving average price of $64.03 and a 200 day moving average price of $62.05. The stock has a market capitalization of $14.48 billion, a PE ratio of 40.65 and a beta of 1.27.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by $0.01. DENTSPLY SIRONA had a return on equity of 7.37% and a net margin of 9.42%. The business had revenue of $900.50 million during the quarter, compared to analyst estimates of $916.55 million. During the same quarter last year, the firm earned $0.69 EPS. DENTSPLY SIRONA’s revenue for the quarter was up 16.6% compared to the same quarter last year. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post $2.84 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 29th will be paid a $0.0875 dividend. This represents a $0.35 annualized dividend and a yield of 0.55%. The ex-dividend date is Thursday, September 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is 22.58%.
TRADEMARK VIOLATION WARNING: “Liberty Mutual Group Asset Management Inc. Has $742,000 Position in DENTSPLY SIRONA Inc. (XRAY)” was reported by BNB Daily and is owned by of BNB Daily. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.baseball-news-blog.com/2017/07/26/liberty-mutual-group-asset-management-inc-lowers-position-in-dentsply-sirona-inc-xray-updated-updated.html.
A number of equities research analysts have commented on the company. Cleveland Research upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a report on Tuesday, May 23rd. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a report on Thursday, July 13th. BidaskClub cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, June 10th. HC Wainwright assumed coverage on DENTSPLY SIRONA in a report on Tuesday, July 11th. They set a “buy” rating and a $74.00 target price on the stock. Finally, Goldman Sachs Group, Inc. (The) cut DENTSPLY SIRONA from a “neutral” rating to a “sell” rating and lowered their target price for the company from $60.00 to $55.00 in a report on Tuesday, May 23rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the stock. DENTSPLY SIRONA currently has an average rating of “Buy” and a consensus target price of $67.92.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.